Stay updated on Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial
Sign up to get notified when there's something new on the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page.

Latest updates to the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page
- Check5 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0 while the study record remains inaccessible.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAn NIH-wide notice about terminology changes now appears above the inaccessible study record, and the site revision number has been updated.SummaryDifference1%

- Check33 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check47 days agoChange DetectedThe study page now displays a 403 Forbidden error, blocking access to the record and replacing the usual content with an access-denied message.SummaryDifference22%

- Check54 days agoChange DetectedThe page's revision tag was updated from v3.6.6 to v3.7.0, signaling a newer version of the page content. It does not modify visible study details or user-facing information.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a new page version. This metadata update does not alter the study content or user-facing information.SummaryDifference0.0%

Stay in the know with updates to Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous TIL MDA-TIL in Recurrent Cancer Clinical Trial page.